{"id":"https://openalex.org/W2046352863","doi":"https://doi.org/10.1016/j.antiviral.2011.08.012","title":"The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication","display_name":"The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication","publication_year":2011,"publication_date":"2011-08-25","ids":{"openalex":"https://openalex.org/W2046352863","doi":"https://doi.org/10.1016/j.antiviral.2011.08.012","mag":"2046352863","pmid":"https://pubmed.ncbi.nlm.nih.gov/21871497"},"language":"en","primary_location":{"id":"doi:10.1016/j.antiviral.2011.08.012","doi":"https://doi.org/10.1016/j.antiviral.2011.08.012","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.antiviral.2011.08.012","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003139456","display_name":"Ga\u00ebtan Billioud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210125048","display_name":"Centre de Recherche en Canc\u00e9rologie de Lyon","ror":"https://ror.org/02mgw3155","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I203339264","https://openalex.org/I4210096427","https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ga\u00ebtan Billioud","raw_affiliation_strings":["INSERM, U1052, 151 Cours Albert Thomas, Lyon 69424 Cedex 03, France. gaetan.billioud@inserm.fr","INSERM, U1052, 151 Cours Albert Thomas, Lyon 69424 Cedex 03, France","Universit\u00e9 Lyon 1, 43 boulevard du 11 Novembre 1918, 69622 Villeurbanne Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM, U1052, 151 Cours Albert Thomas, Lyon 69424 Cedex 03, France. gaetan.billioud@inserm.fr","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210125048"]},{"raw_affiliation_string":"INSERM, U1052, 151 Cours Albert Thomas, Lyon 69424 Cedex 03, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210125048"]},{"raw_affiliation_string":"Universit\u00e9 Lyon 1, 43 boulevard du 11 Novembre 1918, 69622 Villeurbanne Cedex, France","institution_ids":["https://openalex.org/I100532134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090486058","display_name":"Christian Pichoud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210125048","display_name":"Centre de Recherche en Canc\u00e9rologie de Lyon","ror":"https://ror.org/02mgw3155","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I203339264","https://openalex.org/I4210096427","https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christian Pichoud","raw_affiliation_strings":["INSERM, U1052, 151 Cours Albert Thomas, Lyon 69424 Cedex 03, France","Universit\u00e9 Lyon 1, 43 boulevard du 11 Novembre 1918, 69622 Villeurbanne Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM, U1052, 151 Cours Albert Thomas, Lyon 69424 Cedex 03, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210125048"]},{"raw_affiliation_string":"Universit\u00e9 Lyon 1, 43 boulevard du 11 Novembre 1918, 69622 Villeurbanne Cedex, France","institution_ids":["https://openalex.org/I100532134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028477277","display_name":"Gerhard Puerstinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Gerhard Puerstinger","raw_affiliation_strings":["Institut f\u00fcr Pharmazie, Abteilung Pharmazeutische Chemie, Universit\u00e4t Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut f\u00fcr Pharmazie, Abteilung Pharmazeutische Chemie, Universit\u00e4t Innsbruck, Innrain 52a, A-6020 Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089010495","display_name":"Johan H. Neyts","orcid":"https://orcid.org/0000-0002-0033-7514","observed_orcids":["https://orcid.org/0000-0002-0033-7514"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Johan Neyts","raw_affiliation_strings":["Rega Institute, Minderbroedersstraat 10, B 3000 Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rega Institute, Minderbroedersstraat 10, B 3000 Leuven, Belgium","institution_ids":["https://openalex.org/I24156275"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063172143","display_name":"Fabien Zoulim","orcid":"https://orcid.org/0000-0002-2245-0083","observed_orcids":["https://orcid.org/0000-0002-2245-0083"]},"institutions":[{"id":"https://openalex.org/I100532134","display_name":"Lyon 1 Universit\u00e9","ror":"https://ror.org/029brtt94","country_code":"FR","type":"education","lineage":["https://openalex.org/I100532134","https://openalex.org/I203339264"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210125048","display_name":"Centre de Recherche en Canc\u00e9rologie de Lyon","ror":"https://ror.org/02mgw3155","country_code":"FR","type":"facility","lineage":["https://openalex.org/I100532134","https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I203339264","https://openalex.org/I4210096427","https://openalex.org/I4210105738","https://openalex.org/I4210125048"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Fabien Zoulim","raw_affiliation_strings":["Hospices Civils de Lyon, Hepatology Department, 103 Grande-Rue de la Croix-Rousse, 69317 Lyon Cedex 4, France","INSERM, U1052, 151 Cours Albert Thomas, Lyon 69424 Cedex 03, France","Universit\u00e9 Lyon 1, 43 boulevard du 11 Novembre 1918, 69622 Villeurbanne Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospices Civils de Lyon, Hepatology Department, 103 Grande-Rue de la Croix-Rousse, 69317 Lyon Cedex 4, France","institution_ids":["https://openalex.org/I4210100596"]},{"raw_affiliation_string":"INSERM, U1052, 151 Cours Albert Thomas, Lyon 69424 Cedex 03, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210125048"]},{"raw_affiliation_string":"Universit\u00e9 Lyon 1, 43 boulevard du 11 Novembre 1918, 69622 Villeurbanne Cedex, France","institution_ids":["https://openalex.org/I100532134"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5063172143"],"corresponding_institution_ids":["https://openalex.org/I100532134","https://openalex.org/I154526488","https://openalex.org/I4210100596","https://openalex.org/I4210125048"],"apc_list":{"value":4160,"currency":"USD","value_usd":4160},"apc_paid":null,"fwci":3.3606,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.91587868,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"92","issue":"2","first_page":"271","last_page":"276"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-b-virus","display_name":"hepatitis B virus","score":0.8889999985694885},{"id":"https://openalex.org/keywords/hbv-polymerase","display_name":"HBV polymerase","score":0.5659999847412109},{"id":"https://openalex.org/keywords/nucleoside-analogue-resistance","display_name":"nucleoside analogue resistance","score":0.8009999990463257},{"id":"https://openalex.org/keywords/non-nucleoside-inhibitors","display_name":"non-nucleoside inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/rna-encapsidation","display_name":"RNA encapsidation","score":0.9169999957084656},{"id":"https://openalex.org/keywords/lamivudine-resistance","display_name":"lamivudine resistance","score":0.8679999709129333},{"id":"https://openalex.org/keywords/adefovir-resistance","display_name":"adefovir resistance","score":1.0},{"id":"https://openalex.org/keywords/combination-antiviral-therapy","display_name":"combination antiviral therapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/tenofovir","display_name":"tenofovir","score":0.9240000247955322},{"id":"https://openalex.org/keywords/antiviral-resistance","display_name":"antiviral resistance","score":0.7379999756813049},{"id":"https://openalex.org/keywords/chronic-hepatitis-b-treatment","display_name":"chronic hepatitis B treatment","score":0.7570000290870667},{"id":"https://openalex.org/keywords/hbv-replication","display_name":"HBV replication","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.8144709467887878},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.742994487285614},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.7137941122055054},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.6508214473724365},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.563374400138855},{"id":"https://openalex.org/C73616013","wikidata":"https://www.wikidata.org/wiki/Q5731703","display_name":"Hepatitis B virus PRE beta","level":5,"score":0.5471434593200684},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4418952763080597},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.42586684226989746},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4108163118362427},{"id":"https://openalex.org/C194575299","wikidata":"https://www.wikidata.org/wiki/Q2843746","display_name":"Hepatitis B virus DNA polymerase","level":4,"score":0.2684597969055176},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09793251752853394},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.05834349989891052}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006515","descriptor_name":"Hepatitis B virus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006515","descriptor_name":"Hepatitis B virus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006515","descriptor_name":"Hepatitis B virus","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009705","descriptor_name":"Nucleosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D020125","descriptor_name":"Mutation, Missense","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D022781","descriptor_name":"Hepatocytes","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.antiviral.2011.08.012","doi":"https://doi.org/10.1016/j.antiviral.2011.08.012","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.antiviral.2011.08.012","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},{"id":"pmid:21871497","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21871497","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral research","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-00778566v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-00778566","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antiviral Research, 2011, 92 (2), pp.271-6. ⟨10.1016/j.antiviral.2011.08.012⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/321441","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21871497","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antiviral Research, vol. 92 (2), (271-276)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W93400950","https://openalex.org/W112572118","https://openalex.org/W1517213149","https://openalex.org/W1931958712","https://openalex.org/W1969760550","https://openalex.org/W1978314081","https://openalex.org/W1979569154","https://openalex.org/W1981742167","https://openalex.org/W1990213830","https://openalex.org/W2008978159","https://openalex.org/W2010463798","https://openalex.org/W2014383571","https://openalex.org/W2032054046","https://openalex.org/W2042719661","https://openalex.org/W2070339314","https://openalex.org/W2075587088","https://openalex.org/W2075849830","https://openalex.org/W2077945404","https://openalex.org/W2079571554","https://openalex.org/W2092193247","https://openalex.org/W2108892218","https://openalex.org/W2119888523","https://openalex.org/W2136744556","https://openalex.org/W2138808823","https://openalex.org/W2148184464","https://openalex.org/W2163577777","https://openalex.org/W2165502303","https://openalex.org/W2195725578"],"related_works":["https://openalex.org/W3032309761","https://openalex.org/W2038948474","https://openalex.org/W2142999888","https://openalex.org/W1982960788","https://openalex.org/W2075587088","https://openalex.org/W2161853880","https://openalex.org/W2040337342","https://openalex.org/W1981742167","https://openalex.org/W2007179952","https://openalex.org/W2138463909"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}